| AE | Adverse Event |
| AUR | Acute Urinary Retention |
| BoNT | Botulinum Neurotoxin |
| BTX | Botulinum Toxin |
| COL-CAP | Classification System for Cervical Dystonia |
| CGRP | Calcitonin Gene-Related Peptide |
| CPM | Conditioned Pain Modulation |
| GMFCS | Gross Motor Function Classification System |
| MFP | Myofascial Pain (Syndrome) |
| NTNH | Stands for Non-Toxic Non-Hemagglutinin |
| NAbs | Neutralizing Antibodies |
| OAB | Overactive Bladder |
| PREEMPT | Phase III Research Evaluating Migraine Prophylaxis Therapy |
| SNARE | Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor |
| RCT | Randomized Controlled Trial |
| SV2 | Synaptic Vesicle Protein 2 |
| TeNT | Tetanus Neurotoxin |
| UTIs | Urinary Tract Infections |